{"result": {"id": "666beb15-db89-4e20-89eb-506394ba296e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Gemfibrozil** is a fibrate-class lipid-lowering drug administered orally in capsule form, typically in doses of 0.2 or 0.25 grams once daily. As a fibrate, it is primarily used to manage lipid levels in the blood. However, it may cause dangerous interactions when combined with certain medications, such as lovastatin, a statin-class drug. These interactions can pose significant health risks, necessitating caution and medical supervision when co-administered with other lipid-modifying agents. The drug's mechanism of action and therapeutic effects align with its classification as a fibrate, targeting conditions like hypertriglyceridemia or mixed dyslipidemia.  \n\nIn summary, Gemfibrozil is an oral fibrate medication prescribed for lipid regulation, available in specific dosages, but requires careful consideration of potential drug interactions, particularly with statins like lovastatin.", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752167456, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 181, "prompt_tokens": 210, "total_tokens": 391, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 146}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"GEMFIBROZIL\"\nDescription List: [\"A drug that may cause dangerous interactions when combined with lovastatin\\\"\", \"Gemfibrozil is a fibrate drug administered orally in capsule form, 0.2 or 0.25 g per dose, once daily.\\\"\", \"Gemfibrozil is a fibrate-class lipid-lowering drug mentioned in the text\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_b075c848a2c89ad63274bce251109e262d18020ec288e6d7f96e431cf8c9fbbf_v2"}